(R)-4-Methoxy-2-methyl-4-oxobutanoic acid, 95.0%, 1g

Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98.0%, 100g

(S)-TERT-BUTYL 4-ETHYL-1,2,3-OXATHIAZOLIDINE-3-CARBOXYLATE 2,2-DIOXIDE, 95%, 100mg

(2-((4-(Tert-butyl)-2-methylphenoxy)methyl)phenyl)boronic acid, 96%, 5g

4-Chloropyridine-2-carboxamide, 97.0%, 25g

Graphene Nanoplatelets 2-10nm(thick), 5micro m(wide)1g

(1S)-1-(1,3-Thiazol-2-yl)ethan-1-ol, 97%, 500mg

1,4-Bis(bromomethyl)naphthalene (contains isomer)>65.0%(GC)5g

n-Octane [for Spectrophotometry]>98.5%(GC)100mL

2,4,6-Tri(pyridin-4-yl)pyridine>98.0%(HPLC)(N)250mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole, 95.0%, 10g

4-Amino-3-phenyl-butyric acid HCl, 95.0%, 100g

N1-methyl-N1-(tetrahydro-2H-pyran-4-yl)benzene-1,4-diamine, 95%, 250mg